Annual Revenue
$65.30 M
+$16.48 M+33.76%
30 June 2024
Summary:
MEI Pharma annual revenue is currently $65.30 million, with the most recent change of +$16.48 million (+33.76%) on 30 June 2024. During the last 3 years, it has risen by +$30.50 million (+87.66%). MEIP annual revenue is now at all-time high.MEIP Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
30 September 2024
Summary:
MEI Pharma quarterly revenue is not available.MEIP Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
30 September 2024
Summary:
MEI Pharma TTM revenue is not available.MEIP TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MEIP Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.8% | - | - |
| 3 y3 years | +87.7% | - | - |
| 5 y5 years | +1228.5% | - | - |
MEIP Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +87.7% | ||||
| 5 y | 5 years | at high | +1228.5% | ||||
| alltime | all time | at high | >+9999.0% |
MEI Pharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | $65.30 M(+33.8%) | - | - |
| Sept 2023 | - | $65.30 M(+4381.6%) | $105.38 M(+115.9%) |
| June 2023 | $48.82 M(+19.9%) | $1.46 M(-75.3%) | $48.82 M(-16.9%) |
| Mar 2023 | - | $5.89 M(-82.0%) | $58.77 M(-6.1%) |
| Dec 2022 | - | $32.73 M(+275.0%) | $62.57 M(+50.2%) |
| Sept 2022 | - | $8.73 M(-23.5%) | $41.67 M(+2.4%) |
| June 2022 | $40.70 M(+17.0%) | $11.41 M(+17.7%) | $40.70 M(+10.8%) |
| Mar 2022 | - | $9.69 M(-18.1%) | $36.74 M(+4.5%) |
| Dec 2021 | - | $11.83 M(+52.5%) | $35.15 M(-2.1%) |
| Sept 2021 | - | $7.76 M(+4.1%) | $35.91 M(+3.2%) |
| June 2021 | $34.80 M(+25.4%) | $7.45 M(-8.1%) | $34.80 M(-32.7%) |
| Mar 2021 | - | $8.11 M(-35.6%) | $51.69 M(+15.3%) |
| Dec 2020 | - | $12.60 M(+89.7%) | $44.82 M(+34.9%) |
| Sept 2020 | - | $6.64 M(-72.7%) | $33.24 M(+19.7%) |
| June 2020 | $27.76 M(+464.7%) | $24.35 M(+1857.2%) | $27.76 M(+511.5%) |
| Mar 2020 | - | $1.24 M(+23.4%) | $4.54 M(-0.1%) |
| Dec 2019 | - | $1.01 M(-12.9%) | $4.54 M(-18.6%) |
| Sept 2019 | - | $1.16 M(+2.4%) | $5.58 M(+13.6%) |
| June 2019 | $4.92 M(+203.0%) | $1.13 M(-9.5%) | $4.92 M(+13.4%) |
| Mar 2019 | - | $1.25 M(-39.0%) | $4.33 M(+23.2%) |
| Dec 2018 | - | $2.05 M(+319.7%) | $3.52 M(+92.5%) |
| Sept 2018 | - | $488.00 K(-10.9%) | $1.83 M(+12.6%) |
| June 2018 | $1.62 M(-93.0%) | $548.00 K(+26.6%) | $1.62 M(+6.5%) |
| Mar 2018 | - | $433.00 K(+20.9%) | $1.52 M(-72.8%) |
| Dec 2017 | - | $358.00 K(+26.5%) | $5.59 M(-75.1%) |
| Sept 2017 | - | $283.00 K(-37.0%) | $22.44 M(-3.5%) |
| June 2017 | $23.25 M | $449.00 K(-90.0%) | $23.25 M(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $4.50 M(-73.8%) | $22.80 M(+24.6%) |
| Dec 2016 | - | $17.20 M(+1469.3%) | $18.30 M(+1569.3%) |
| Sept 2016 | - | $1.10 M(+4115.4%) | $1.10 M(+593.7%) |
| Sept 2009 | - | $26.00 K(-3.7%) | $158.00 K(-30.7%) |
| June 2009 | $228.00 K(-66.2%) | $27.00 K(-6.9%) | $228.00 K(-22.2%) |
| Mar 2009 | - | $29.00 K(-61.8%) | $293.00 K(-29.1%) |
| Dec 2008 | - | $76.00 K(-20.8%) | $413.00 K(-25.2%) |
| Sept 2008 | - | $96.00 K(+4.3%) | $552.00 K(-18.1%) |
| June 2008 | $674.00 K(+4.5%) | $92.00 K(-38.3%) | $674.00 K(-8.7%) |
| Mar 2008 | - | $149.00 K(-30.7%) | $738.00 K(-2.9%) |
| Dec 2007 | - | $215.00 K(-1.4%) | $760.00 K(+4.4%) |
| Sept 2007 | - | $218.00 K(+39.7%) | $728.00 K(+12.9%) |
| June 2007 | $645.00 K(+344.8%) | $156.00 K(-8.8%) | $645.00 K(+31.9%) |
| Mar 2007 | - | $171.00 K(-6.6%) | $489.00 K(+16.7%) |
| Dec 2006 | - | $183.00 K(+35.6%) | $419.00 K(+14.5%) |
| Sept 2006 | - | $135.00 K(+33.7%) | $366.00 K(+3.7%) |
| Mar 2006 | - | $101.00 K(-22.3%) | $353.00 K(+9.3%) |
| Dec 2005 | - | $130.00 K(+6.6%) | $323.00 K(+25.7%) |
| Sept 2005 | - | $122.00 K(+71.8%) | $257.00 K(+27.2%) |
| Mar 2005 | - | $71.00 K(+10.9%) | $202.00 K(-1.9%) |
| Dec 2004 | - | $64.00 K(-4.5%) | $206.00 K(+45.1%) |
| Sept 2004 | - | $67.00 K(-10.7%) | $142.00 K(+12.7%) |
| Mar 2004 | - | $75.00 K(+257.1%) | $126.00 K(+44.8%) |
| Sept 2003 | - | $21.00 K(-30.0%) | $87.00 K(+31.8%) |
| June 2003 | $145.00 K(+1971.4%) | $30.00 K(-16.7%) | $66.00 K(+83.3%) |
| Mar 2003 | - | $36.00 K | $36.00 K |
| June 2002 | $7000.00 | - | - |
FAQ
- What is MEI Pharma annual revenue?
- What is the all time high annual revenue for MEI Pharma?
- What is MEI Pharma annual revenue year-on-year change?
- What is the all time high quarterly revenue for MEI Pharma?
- What is the all time high TTM revenue for MEI Pharma?
What is MEI Pharma annual revenue?
The current annual revenue of MEIP is $65.30 M
What is the all time high annual revenue for MEI Pharma?
MEI Pharma all-time high annual revenue is $65.30 M
What is MEI Pharma annual revenue year-on-year change?
Over the past year, MEIP annual revenue has changed by +$16.48 M (+33.76%)
What is the all time high quarterly revenue for MEI Pharma?
MEI Pharma all-time high quarterly revenue is $65.30 M
What is the all time high TTM revenue for MEI Pharma?
MEI Pharma all-time high TTM revenue is $105.38 M